- Home
- AVAL vs BEAM Comparison
AVAL vs BEAM Comparison
Compare AVAL & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAL
- BEAM
- Stock Information
- Founded
- AVAL 1994
- BEAM 2017
- Country
- AVAL Colombia
- BEAM United States
- Employees
- AVAL N/A
- BEAM N/A
- Industry
- AVAL Commercial Banks
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVAL Finance
- BEAM Health Care
- Exchange
- AVAL Nasdaq
- BEAM Nasdaq
- Market Cap
- AVAL 2.4B
- BEAM 1.9B
- IPO Year
- AVAL N/A
- BEAM 2020
- Fundamental
- Price
- AVAL $2.25
- BEAM $23.44
- Analyst Decision
- AVAL
- BEAM Buy
- Analyst Count
- AVAL 0
- BEAM 10
- Target Price
- AVAL N/A
- BEAM $47.67
- AVG Volume (30 Days)
- AVAL 51.2K
- BEAM 1.3M
- Earning Date
- AVAL 03-03-2025
- BEAM 02-25-2025
- Dividend Yield
- AVAL 5.07%
- BEAM N/A
- EPS Growth
- AVAL 150.80
- BEAM N/A
- EPS
- AVAL 0.01
- BEAM N/A
- Revenue
- AVAL $2,745,537,342.00
- BEAM $349,643,000.00
- Revenue This Year
- AVAL N/A
- BEAM N/A
- Revenue Next Year
- AVAL $15.37
- BEAM $10.82
- P/E Ratio
- AVAL $13.35
- BEAM N/A
- Revenue Growth
- AVAL N/A
- BEAM 328.73
- 52 Week Low
- AVAL $1.94
- BEAM $20.84
- 52 Week High
- AVAL $2.71
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- AVAL 66.37
- BEAM 38.04
- Support Level
- AVAL $2.21
- BEAM $22.50
- Resistance Level
- AVAL $2.18
- BEAM $28.39
- Average True Range (ATR)
- AVAL 0.05
- BEAM 1.68
- MACD
- AVAL 0.02
- BEAM -0.41
- Stochastic Oscillator
- AVAL 90.74
- BEAM 15.05
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.